📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

A quantitative, multi-national and multi-stakeholder assessment of barriers to the adoption of cell therapies. (2017)

First Author: Davies BM

Attributed to: RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/2041731417724413

PubMed Identifier: 28835816

Publication URI: http://europepmc.org/abstract/MED/28835816

Type: Journal Article/Review

Volume: 8

Parent Publication: Journal of tissue engineering

ISSN: 2041-7314